The European Rare Kidney Disease Reference Network


Journal Watch

Thrombotic microangiopathies

Treatment of hemolytic uremic syndrome related to Bordetella pertussis infection -is plasma exchange or eculizumab use necessary?
Author(s): Saida K, Ogura M, Kano Y, Ishimori S, Yoshikawa T, Nagata H, Sato M, Kamei K, Ishikura K
Source: BMC Nephrol 2018 Dec 17;19(1):365
Publication date: 2018-12-17
Hemolytic uremic syndrome associated with Bordetella pertussis infection in a 2-month-old infant carrying a pathogenic variant in complement factor H.
Author(s): Madden I, Roumenina LT, Langlois-Meurinne H, Guichoux J, Llanas B, Frémeaux-Bacchi V, Harambat J, Godron-Dubrasquet A
Source: Pediatr Nephrol 2018 Dec 17;
Publication date: 2018-12-17
Complement Activation Contributes to the Pathophysiology of Shiga Toxin-Associated Hemolytic Uremic Syndrome.
Author(s): Buelli S, Zoja C, Remuzzi G, Morigi M
Source: Microorganisms 2019 Jan 10;7(1)
Publication date: 2019-01-10
Complement Gene Variants and Shiga Toxin-Producing Escherichia coli-Associated Hemolytic Uremic Syndrome: Retrospective Genetic and Clinical Study.
Author(s): Frémeaux-Bacchi V, Sellier-Leclerc AL, Vieira-Martins P, Limou S, Kwon T, Lahoche A, Novo R, Llanas B, Nobili F, Roussey G, Cailliez M, Ulinski T, Deschênes G, Alberti C, Weill FX, Mariani P, Loirat C
Source: Clin J Am Soc Nephrol 2019 Jan 23;
Publication date: 2019-01-23
+ Show 32 more...